Abstract. During the course of experiments designed to determine whether infection of normal cells with certain strains of Herpesvirus hominis (HSV) gives rise to a specific neoantigen, presumably characteristic for human malignant cells ("HeLa G"), it was found that the seeming appearance of such a new antigen actually represents only an increase in concentration of previously existing normal antigen groups. The complement fixation tests for this antigen were carried out with antibody prepared by McKenna against a fraction, purified with the fluorocarbon genetron, from HeLa cells. This antibody reacted with extracts of tissue culture cells derived from various human malignant tumors and from the spontaneously transformed WISH cell line, originally derived from normal human amnion, but not with cells derived from early-passage cultures of normal human kidney, or from primary cultures of young rabbit kidney or newborn guinea pig kidney.
Infection of rabbit and guinea pig kidney tissue culture cells with HSV strains derived from brain or lip lesions at a high input multiplicity of virus failed to yield the "G" antigen. Infection of human kidney tissue culture cells with the same HSV strains yielded two units of the "G" antigen at 6 hr and 32 units at 24 hr. The conclusion that this was, nevertheless, not a new antigen, but only an increase in amount of preexisting antigen, was based on the demonstration that absorption of the anti-"HeLa G" globulin with uninfected human kidney tissue culture cells completely removed the antibody for the "G" anltigen formed during the course of infection with HSV and also that present in uninfected WISH and HEp2 cells.
Infection by the same HSV strains of the human WISH cells which have a small amount of preexisting "G" antigen resulted in an increase which was maximal at 24 hr. Infection of WISH cells with vaccinia virus resulted in a rapid increase of "G" antigen, which was demonstrable at 10 mill but not at 3, 6, and 24 hr. Absorption of the anti-"HeLa G" globulin with uninfected WISH cells removed the antibody for the G antigen present in the WISH cells before infection as well as after infection with the herpes and vaccinia viruses, and also the antigen present in human tissue culture cells of malignant origin. 3i\Cl~elllal c al. -;3reported that antisera I)rel)ared against a fluOrocarl)onl-73)1 purified antigen from HeLa cells and other malignant human tumor cells had specific complement-fixing and precipitating antibody for many human malignant tumors and tumor cell lines but not for benign human tumors or normal human tissues or cell lines derived from them. McKenna et al.4 also reported that when a "normal," human amnion cell line, "WISH" I (which was nonreactive in gel precipitation tests), was infected with HSV strains derived from human lip lesions, this "malignant" antigen appeared in 6-12 hr. A strain of HSV recovered from the brain of a patient with herpetic encephalitis and a strain of vaccinia virus were reported as yielding negative results under the same conditions. These data were interpreted as favoring the hypothesis that certain HSV strains were oncogenic in man,4 and this work has been quoted in support of the hypothesis that genital HSV may be a cause of human cervical carcinoma.
Since these data had a bearing on our own search for nonvirion HSV antigens with which the possible role of HSV as a cause of certain human malignancies might be tested,7 we decided to study the nature of the "HeLa G" antigen.
Materials and Methods. Theprocedures used for propagation of various cells, the preparation of CF antigens and the CF test, the "Schooler" strain of HSV and the VL strain of vaccinia, and the antiviral sera used for monitoring the synthesis of virion antigens were all described in a recent communication. for this work. The HSV (13 H) strain, derived from a lip lesion, was obtained from Dr. T. Tokumaru (Children's Hospital of Philadelphia, Pa.); it was passaged in primary young rabbit kidney (YRK) tissue cultures yielding titers of 8 X 108 plaque-forming units per ml of 10% cell suspension extract in secondary YRK cells. The anti-HeLa G antibody was contained in globulin derived from the serum of a horse inoculated with several doses of the purified HeLa G fraction mixed with complete Freund's adjuvant. The globulin (precipitated five times with 33.3% ammonium sulfate) was kindly supplied in lyophilized form by Dr. John M. McKenna. Upon reconstitution in Ca-Mg saline containing 0.2% gelatin, it was not anticomplementary at the 500 ,g/ml concentration in which it was used. According to Dr. McKenna this concentration of the globulin failed to react in the CF test with "normal human tissue protein" at a concentration of 500 /Ag/ml but did react with 1 4g/ml of HeLa G antigen. We found that this globulin reacted with our concentrated HSV preparations derived from HEp2 cells but not with preparations derived from YRK cells grown in calf serum, which were used in all the tests described in this communication.
Absorption of the globulin solution (500 sg/ml) with either WISH or 12th-passage human kidney cells was carried out as follows. 0.3-0.4 ml of intact packed cells was suspended in the globulin solution and incubated at 370C for 2 hr with frequent shaking. The supernatant fluid obtained after centrifugation at 500 g for 10 min was again added to 0.3-0.4 ml quantities of packed cells and incubation and centrifugation were repeated as before. The process was repeated a third time but the incubation was at +40C overnight on a shaking machine. In order to remove the anticomplementary activity of the antigen-antibody complexes, the final centrifugation was at 37,000 rpm (average 90,300 g) for 2 hr using the supernatant fluid from a preliminary centrifugation at 1500 g for 10 mins. Table 1 show that the YRK cells, which had no demonstrable "G" antigen prior to infection, developed none during the course of infection. Negative results were also obtained in a similar experiment with newborn guinea pig kidney cultures, not shown in this table. On the other hand, the WISH cells (McKenna line) which had only 4-6 units of antigen at about 10 min and 6 hr after infection, exhibited 16 units ("Schooler" strain) and 32 units ("Tokumaru" strain) at 24 hr, when all cells showed the cytopathic effect. It is noteworthy that in this experiment the uninfected cells, manipulated in the same way and harvested 24 hr after the change to serum-free medium, had only 1.5 units in the 10% cell extract. Table 4 indicate that the uninfected human kidney tissue culture cells > 1 X X E_-~~~-z contained no significantly demonstrable G antigen, and that, as in the case of the WISH cells, G antigen first appeared at 6 hr and reached levels of 32 units at 24 hr. Absorption of the anti-HeLa G globulin with normal, intact, uninfected, human kidney tissue culture cells removed all reactivity with the antigen groups, which became apparent in these cells after infection (Table 4) , and also with those present in the spontaneously transformed human WISH cells and in the human HEp2 cells of malignant origin (data not shown in Table 4 ). Addendum: It should be noted that comparable absorption of the anti-HeLa G globulin with similar amounts of young rabbit kldney tissue culture cells had no significant effect on the CF titer against uninfected HEp2 and WISH cells as well as WISH and normal human kidney tissue culture cells infected with HSV.
Results. HeLa G antigen in YRK and WISH cells infected with HSV (10 PFU/cell): The data in
Comment. The results of the present study throw light on some changes that occur in the number of combining groups of at least one preexisting human cell wall antigen at different times after infection with different viruses. It is also evident that a similar change in configuration or available combining groups of this normal antigen appears, to varying degrees, in certain spontaneously transformed human cells and in cells cultured from certain human malignant tumors. The present data also reemphasize the pitfalls that must be avoided in work on so-called "neoantigens" in malignant cells.
It is remarkable that in the case of vaccinia virus the increase in the preexisting antigen combining groups appeared within 10 min after high multiplicity infection and disappeared by the time viral synthesis began and continued to completion, while in the case of the herpes viruses used in these tests this change began concurrently with or shortly after the beginning of viral synthesis and reached a maximum at the completion of the infectious process. The fact that the phenomenon was not demonstrated in rabbit and guinea pig cells with the antiserum prepared against a human cell fraction is compatible with the conclusion, based also on the absorption data, that we are dealing with a preexisting human cell wall antigen. The assumption that we are dealing with a cell wall antigen is based on the finding that intact cells absorbed the antibody. The conclusion that this particular antigen is present in normal human cells, in amounts too small to be detected by the methods used, is based on the observation that absorption with such normal, "negative," intact cells removed the antibody to the antigen that became demonstrable after viral infection and that was demonstrable in lower concentration in the uninfected, human, spontaneously transformed WISH cells and Hep2 cells of malignant origin. 
